Table 1.
Effects of cannabidiol on different types of cancer
Cancer | In vitro effect | Receptor involvement | ROS production | Molecular cell signalling | Autophagy | Apoptosis | In vivo effect | Reference |
---|---|---|---|---|---|---|---|---|
Breast | ↓ proliferation | CB2; | ↑ | NC | NC | + | ↓ xenografts growth | [26] |
TRPV1 | ↓ lung metastases | |||||||
↓ viability | non-CB1; | ↑ | ↓ pAkt; ↑ cytochrome C | + | + | NC | [29] | |
non-CB2; | ||||||||
non-TRPV1 | Bid translocation | |||||||
↓ invasion | NC | ↑ | ↓ Id-1; ↑ pERK | NC | NC | ↓ tumour growth | [27, 28] | |
↓ size and number of metastases | ||||||||
Glioma | ↓ proliferation | non-CB1; | ↑ | ↓ pERK; ↓ pAkt; ↓ HIF-1α | NC | + | ↓ tumour growth | [32, 33, 36, 37] |
partial-CB2; | ↑ cytochrome C | |||||||
non-TRPV1 | caspase activation | |||||||
↓ proliferation and invasiveness | NC | NC | NC | NC | NC | NC | [34] | |
↓ migration | non-CB1; | NC | Ptx insensitive | NC | NC | NC | [38] | |
non-CB2; | ||||||||
non-TRPV1 | ||||||||
Leukaemia | ↓ viability | NC | NC | caspase-3 activation | NC | + | NC | [39] |
↓ viability | CB2 | ↑ | ↓ p-p38 | NC | + | ↓ tumour burden | [40] | |
caspase activation; ↓ Bid | ↑ tumour cell apoptosis | |||||||
↑ cytochrome C | ||||||||
Lung | ↓ invasion | CB1; | NC | ↑ p-p38; ↑ p-ERK; ↑ TIMP-1 | NC | NC | ↓ lung metastases | [46, 47] |
CB2; | ||||||||
TRPV1 | ↓ PAI-1 | ↓ PAI-1 in xenografts | ||||||
Thyroid thymoma | cytostatic effect | NC | NC | NC | NC | + | NC | [26] |
↓ viability | NC | ↑ | NC | NC | + | NC | [50] | |
Colon | ↓ proliferation | CB1; | NC | ↓ Akt; ↑ 2-AG | NC | + | ↓ ACF, polyps and tumours | [52] |
TRPV1; | ||||||||
PPARγ | ↑ caspase-3 |
NC = not checked. ↑ increase; ↓ decrease.